Efficacy and tolerability of combination therapy with alpha-blockers and phosphodiesterase-5 inhibitors compared with monotherapy for lower urinary tract symptoms-Reference-Cited by-同舟云学术

Efficacy and tolerability of combination therapy with alpha-blockers and phosphodiesterase-5 inhibitors compared with monotherapy for lower urinary tract symptoms

Published:2020-10-23 Issue:43 Volume:99 Page:e22834
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Qiangzhao Liu,Xiaofeng Zhang,Fenghai Zhou,Qiong Lian,Fa Zhang,Bohong Guo,Xinsheng Xi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference30 articles.

1. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH);Rosen;Eur Urol,2005

2. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction;Kaplan;Eur Urol,2007

3. Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed;Boyle;Eur Urol,1991

4. Erectile dysfunction and lower urinary tract symptoms;De Nunzio;Curr Urol Rep,2018

5. Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: a randomised, double-blind, placebo-controlled trial;Fawzi;Arab J Urol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review;Cureus;2023-12-30

2. A Review of Combined Phosphodiesterase-5-Inhibitors and α-Blockers versus Phosphodiesterase-5-Inhibitors Alone for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia;Arab Journal of Urology;2023-06-13

3. Comparative evaluation of the effectiveness and safety of different dosages of Glancin (tamsulosin) in the treatment of patients with lower urinary tract symptoms due to benign prostatic hyperplasia;Urology reports (St. - Petersburg);2023-01-22

4. Is tadalafil associated with decreased risk of major adverse cardiac events or venous thromboembolism in men with lower urinary tract symptoms?;World Journal of Urology;2022-04-25

5. Utilization of a micellar matrix for simultaneous spectrofluorimetric estimation of alfuzosin hydrochloride and vardenafil hydrochloride;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2022-02